0001638599-20-000654.txt : 20200702 0001638599-20-000654.hdr.sgml : 20200702 20200702180722 ACCESSION NUMBER: 0001638599-20-000654 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clauson Luke CENTRAL INDEX KEY: 0001736840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 201011277 MAIL ADDRESS: STREET 1: C/O EYENOVIA, INC. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4_6774.xml PRIMARY DOCUMENT X0306 4 2020-06-30 0 0001682639 EYENOVIA, INC. EYEN 0001736840 Clauson Luke C/O EYENOVIA, INC. 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 0 1 0 0 VP, R&D and Manufacturing Stock Option (right to buy) 2.72 2020-06-30 4 A 0 101358 0.00 A 2030-06-02 Common Stock 101358 101358 D Stock Option (right to buy) 1.95 2027-07-07 Common Stock 100264 100264 D Stock Option (right to buy) 6.20 2028-07-24 Common Stock 19874 19874 D Stock Option (right to buy) 3.11 2029-08-16 Common Stock 42722 42722 D This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. The option was exercisable as to 2,785 shares on August 7, 2017 and becomes exercisable in equal 2,785 share amounts on each of the 35 one-month anniversaries thereafter. One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. /s/ S. Halle Vakani, Attorney-in-Fact 2020-07-02